| Total | TyG(−)&HOMA-IR(−) | TyG(+)&HOMA-IR(−) | TyG(−)&HOMA-IR(+) | TyG(+)&HOMA-IR(+) | P value |
---|---|---|---|---|---|---|
N | 2446 | 1530 | 304 | 305 | 307 | Â |
Age (year) | 59.17 ± 8.94 | 58.64 ± 9.04 | 59.58 ± 8.62 | 60.64 ± 9.09 | 59.92 ± 8.40 | 0.0004 |
Male, n(%) | 968 (39.6) | 599 (39.2) | 148 (48.7) | 102 (33.4) | 119 (38.8) | 0.51 |
Current smoking, n(%) | 488 (20.0) | 311 (20.3) | 84 (27.6) | 40 (13.1) | 53 (17.3) | 0.05 |
Current drinking, n(%) | 443 (18.1) | 268 (17.5) | 73 (24.0) | 54 (17.7) | 48 (15.6) | 0.72 |
Physical activity (MET-h/wk) | 23.10 (11.55–46.20) | 23.10 (11.55–46.20) | 23.10 (11.55–46.20) | 23.10 (11.55–46.20) | 23.10 (11.55–37.10) | 0.005 |
Highschool education, n(%) | 1949 (79.7) | 1255 (82.0) | 242 (79.6) | 222 (72.8) | 230 (74.9) | < 0.0001 |
SBP (mmHg) | 135.98 ± 20.19 | 132.82 ± 19.91 | 138.04 ± 19.29 | 141.57 ± 19.78 | 143.99 ± 19.23 | < 0.0001 |
DBP (mmHg) | 78.36 ± 9.79 | 76.84 ± 9.70 | 79.64 ± 9.59 | 80.71 ± 9.27 | 82.23 ± 9.24 | < 0.0001 |
PP (mmHg) | 57.63 ± 16.38 | 55.98 ± 16.00 | 58.40 ± 15.63 | 60.86 ± 17.07 | 61.76 ± 17.00 | < 0.0001 |
Height (cm) | 159.93 ± 7.92 | 159.92 ± 7.75 | 160.53 ± 8.09 | 159.30 ± 7.81 | 159.99 ± 8.67 | 0.74 |
Weight (kg) | 64.49 ± 10.59 | 62.17 ± 9.62 | 65.14 ± 9.58 | 69.92 ± 11.12 | 69.93 ± 11.58 | < 0.0001 |
BMI (kg/m2) | 25.17 ± 3.50 | 24.28 ± 3.19 | 25.20 ± 2.85 | 27.50 ± 3.54 | 27.29 ± 3.57 | < 0.0001 |
FPG (mmol/L) | 5.13 (4.70–5.82) | 4.90 (4.60–5.30) | 5.50 (5.00–6.20) | 5.60 (5.00–6.50) | 6.90 (5.70–9.00) | < 0.0001 |
Fasting insulin (μIU/ml) | 7.00 (4.57–10.26) | 5.57 (3.85–7.59) | 6.81 (4.97–8.54) | 14.04 (12.09–17.03) | 12.95 (10.57–17.33) | < 0.0001 |
Post load glucose (mmol/L) | 7.60 (6.10–11.30) | 6.90 (5.60–8.40) | 8.80 (7.00–13.20) | 9.10 (7.00–14.55) | 14.70 (10.70–19.25) | < 0.0001 |
HbA1c (%) | 6.10 (5.80–6.60) | 5.90 (5.70–6.20) | 6.30 (5.80–6.90) | 6.40 (6.00–7.10) | 7.40 (6.50–8.90) | < 0.0001 |
HOMA-IR | 1.65 (1.03–2.63) | 1.25 (0.82–1.73) | 1.79 (1.32–2.22) | 3.45 (2.92–4.34) | 4.01 (3.18–5.73) | < 0.0001 |
Total cholesterol (mmol/L) | 5.15 ± 0.96 | 5.03 ± 0.89 | 5.42 ± 1.03 | 5.01 ± 0.98 | 5.63 ± 1.04 | < 0.0001 |
Triglyceride (mmol/L) | 1.41 (0.97–2.07) | 1.16 (0.86–1.54) | 2.89 (2.44–3.62) | 1.35 (1.00–1.68) | 2.65 (2.11–3.43) | < 0.0001 |
HDL cholesterol (mmol/L) | 1.36 ± 0.31 | 1.42 ± 0.32 | 1.26 ± 0.25 | 1.29 ± 0.29 | 1.24 ± 0.20 | < 0.0001 |
LDL cholesterol (mmol/L) | 2.39 ± 0.68 | 2.35 ± 0.63 | 2.29 ± 0.74 | 2.53 ± 0.66 | 2.52 ± 0.80 | < 0.0001 |
UACR (mg/g) | 4.89 (2.45–9.23) | 4.58 (2.32–8.40) | 4.41 (2.42–9.47) | 6.02 (2.92–11.92) | 6.24 (2.93–12.13) | < 0.0001 |
eGFR (ml/min/1.73m2) | 90.90 ± 12.75 | 91.25 ± 12.58 | 90.13 ± 12.90 | 89.66 ± 12.96 | 91.22 ± 13.20 | 0.31 |
TyG index | 8.74 ± 0.68 | 8.40 ± 0.45 | 9.53 ± 0.32 | 8.68 ± 0.41 | 9.72 ± 0.52 | < 0.0001 |
Medication use of ACEIs or ARBs, n(%) | 74 (3.0) | 33 (2.2) | 8 (2.6) | 13 (4.3) | 20 (6.5) | < 0.0001 |
Diabetes, n(%) | 860 (35.2) | 310 (20.5) | 138 (46.0) | 167 (54.8) | 245 (80.1) | < 0.0001 |
Hypertension, n(%) | 1281 (52.4) | 674 (45.1) | 186 (61.6) | 199 (66.3) | 222 (72.6) | < 0.0001 |
History of MACEs, n(%) | 213 (8.7) | 112 (7.3) | 37 (12.2) | 28 (9.2) | 36 (11.7) | 0.007 |
MACEs at follow-up visit, n(%) | 160 (6.5) | 89 (5.8) | 29 (9.5) | 18 (5.9) | 24 (7.8) | 0.20 |